Santhera: The doctor takes chargeDeveloper of treatments for neuromuscular and neuro-ophthalmological diseases Santhera Pharmaceuticals has hired Kristina Sjöblom Nygren as Chief Medical Officer and Head of Development. more ➔
Virovet: Veterinarian comes on boardBelgian ViroVet NV, which develops vaccines and antiviral drug for livestock, has named George Gunn as the newest member of its board of directors. Until early 2015, Gunn was CEO of Novartis Animal Health … more ➔
Eppendorf: Veteran supervisorPromega-founder William Linton has been elected as a member of the Supervisory Board of lab supplier Eppendorf AG. more ➔
Ixico: Taking over from the founderLondon-based brain health company Ixico has hired Giulio Cerroni as its new Chief Executive Officer. Cerroni replaced co-founder Derek Hill, who will remain on the board and serve as executive director … more ➔
Mithra Pharmaceuticals: Master of financeMithra Pharmaceuticals, a Belgian company focused on women’s health, has appointed Christophe Maréchal as Chief Financial Officer. more ➔
Therachon: Pipeline builderSwiss rare genetic diseases company Therachon AG has named Luca Santarelli Chief Executive Officer and Director. Santarelli brings widespred experience from his role as Venture Partner at Versant Ventures, … more ➔
Morphosys: Driving developmentMalte Peters will leave Sandoz to take over as Chief Development Officer of Morphosys AG. Peters succeeds Arndt Schottelius, who held the position for eight yeara. more ➔
Albumedix: Medical expertiseNovozymes company Albumedix A/S has appointed Giles Campion new Chief Medical Officer. Campion will be in charge of leading the development efforts of the Danish leader in albumin-based drug deliver … more ➔
Newron Pharmaceuticals: Commercial headMilan-based Newron Pharmaceuticals has named Dennis Dionne Vice President Commercial Affairs. Previously, Dionne was Executive Director for Commercial Operations. He replaces Anders Haegerstrand. more ➔
Viiv Healthcare: New at the helmDeborah Waterhouse, currently Senior Vice President Primary Care, GSK US Pharmaceuticals, will take over as CEO of Viiv Healthcare. She succeeds Dominique Limet, who will step down from the post at the … more ➔
